Cancer treatment has always been a balancing act—hit the tumor hard enough to kill it, but not so hard that the patient ...

An exosome-based treatment of glioblastoma multiforme (GBM) has received orphan drug designation from the FDA. 1 Exousia AI, ...

Trump Warns of Threat to Social Security, Medicare Exclusive: Three-star general pushed out amid tensions with Hegseth GM to ...

Many cancer survivors live with the worry that their cancer might come back. This "recurrence" occurs when cancer cells hide somewhere in the body—like in the bone marrow—and start growing again, ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to the antibody-drug conjugate JSKN003 for the ...

A research team led by the Medical University of Vienna, the HUN-REN Research Centre for Natural Sciences and the Eötvös Loránd University in Budapest has developed a groundbreaking new ...

Scientists from King's College London have successfully applied a new technology that disarms one of the most potent weapons ...

Vivan Therapeutics is a pioneer in cancer treatment innovation through its novel approach to personalized medicine. By using ...

Of the 2.3 million women diagnosed annually with breast cancer worldwide, research shows more than half report having ...

Researchers found that lung and skin cancer patients who got COVID-19 vaccines reported significantly increased survival ...

Dr Shaikh shared that MPNST cancer cells rely on sugar metabolism, and inhibiting this process can help treat the disease.

Exousia Pro, Inc., a clinical-stage biotech company that specializes in the use of exomes to treat cancer and other illnesses ...